470
Participants
Start Date
May 31, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Imiquimod
daily topical application for up to 8 weeks
3.75% imiquimod cream
3.75% imiquimod cream applied daily to wart areas for up to 8 weeks.
placebo cream
placebo cream applied daily to wart areas for up to 8 weeks
Private Practice, Purchase
Private Practice, Great Neck
State University of NY Stony Brook, Stony Brook
Philadelphia Institute of Dermatology, Philadelphia
Atlanta North Gynecology, Roswell
Perimeter Institute for Clinical Research, Atlanta
Medical College of Georgia, Augusta
Miami Research Associates, South Miami
Segal Institute for Clinical Research, North Miami
Discovery Clinical Research, Sunrise
Visions Clinical Research, Boynton Beach
Montgomery Women's Health Associates, Montgomery
WILMAX Clinical Research, Mobile
Indiana University Infectious Disease Research Group, Indianapolis
Dermatology Practice, Ann Arbor
Alegent Health Clinic, Omaha
University of Texas Southwestern Medical Center Dermatology Dept, Dallas
Progressive Clinical Research, San Antonio
Professional Quality Research, Women Partners in Health, Austin
Professional Quality Research, The Urology Team, Austin
Colorado Medical Research Center, Denver
Clinicos, LLC, Colorado Springs
Women's Health Research, Phoenix
Precision Trials, Phoenix
Premier Pharmaceutical Research, Tempe
Visions Clinical Research, Tucson
Torrance Clinical Research, Torrance
Edinger Medical Group Clinical Research Center, Fountain Valley
Coastal Medical Research Group, San Luis Obispo
East Bay Dermatology Medical Group, Fremont
Lead Sponsor
Graceway Pharmaceuticals, LLC
INDUSTRY